cHMGCS Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of cHMGCS Antibodies for research in the field of metabolic regulation. cHMGCS Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The cHMGCS protein, or cytosolic 3-hydroxy-3-methylglutaryl-CoA synthase, plays a crucial role in the mevalonate pathway, which is essential for cholesterol and steroid biosynthesis. Its regulation is vital for maintaining cellular homeostasis and has implications in various metabolic disorders. Understanding the function and regulation of cHMGCS can provide insights into therapeutic targets for diseases related to lipid metabolism. Research focusing on cHMGCS has revealed significant connections to cardiovascular health and metabolic syndromes. Investigating cHMGCS expression patterns helps researchers better understand cellular responses to metabolic stress. The role of cHMGCS in cholesterol synthesis pathways continues to be an active area of scientific exploration. Santa Cruz Biotechnology monoclonal antibodies for cHMGCS support researchers worldwide in advancing our understanding of metabolic diseases and potential therapeutic interventions.